Clinical pharmacokinetic and pharmacodynamic profile of lenvatinib, an orally active, small-molecule, multitargeted tyrosine kinase inhibitor - Hussein, Z; Mizuo, H; Hayato, S; Namiki, M; Shumaker, R (Eur J Drug Metab Pharmacokinet, 2017)